CLX Quote, Financials, Valuation and Earnings

Colgate-Palmolive Co. has a net margin of 9.62% compared to The Clorox Co.'s net margin of -0.1%. The Clorox Co.'s return on equity of 398.55% beat Colgate-Palmolive Co.'s return on equity of 287.39%.

The Clorox Co. has a consensus price target of $122.06, signalling downside risk potential of -3.08%. On the other hand Colgate-Palmolive Co. has an analysts' consensus of $95.32 which suggests that it could fall by -1.4%. Given that The Clorox Co. has more downside risk than Colgate-Palmolive Co., analysts believe Colgate-Palmolive Co. is more attractive than The Clorox Co..

The Clorox Co. has a beta of 0.595, which suggesting that the stock is 40.538% less volatile than S&P 500. In comparison Colgate-Palmolive Co. has a beta of 0.290, suggesting its less volatile than the S&P 500 by 70.969%.

The Clorox Co. has a quarterly dividend of $1.24 per share corresponding to a yield of 3.92%. Colgate-Palmolive Co. offers a yield of 2.15% to investors and pays a quarterly dividend of $0.52 per share. The Clorox Co. pays 75.19% of its earnings as a dividend. Colgate-Palmolive Co. pays out 78.33% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

The Clorox Co. quarterly revenues are $1.7B, which are smaller than Colgate-Palmolive Co. quarterly revenues of $5.2B. The Clorox Co.'s net income of $161M is higher than Colgate-Palmolive Co.'s net income of -$5M. Notably, The Clorox Co.'s price-to-earnings ratio is 20.58x while Colgate-Palmolive Co.'s PE ratio is 36.88x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for The Clorox Co. is 2.30x versus 3.85x for Colgate-Palmolive Co.. Usually stocks with elevated PS ratios are considered overvalued.

Kimberly-Clark Corp. has a net margin of 9.62% compared to The Clorox Co.'s net margin of 9.58%. The Clorox Co.'s return on equity of 398.55% beat Kimberly-Clark Corp.'s return on equity of 127.51%.

The Clorox Co. has a consensus price target of $122.06, signalling downside risk potential of -3.08%. On the other hand Kimberly-Clark Corp. has an analysts' consensus of $118.71 which suggests that it could grow by 8.5%. Given that Kimberly-Clark Corp. has higher upside potential than The Clorox Co., analysts believe Kimberly-Clark Corp. is more attractive than The Clorox Co..

The Clorox Co. has a beta of 0.595, which suggesting that the stock is 40.538% less volatile than S&P 500. In comparison Kimberly-Clark Corp. has a beta of 0.261, suggesting its less volatile than the S&P 500 by 73.877%.

The Clorox Co. has a quarterly dividend of $1.24 per share corresponding to a yield of 3.92%. Kimberly-Clark Corp. offers a yield of 4.61% to investors and pays a quarterly dividend of $1.26 per share. The Clorox Co. pays 75.19% of its earnings as a dividend. Kimberly-Clark Corp. pays out 83.09% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

The Clorox Co. quarterly revenues are $1.7B, which are smaller than Kimberly-Clark Corp. quarterly revenues of $4.1B. The Clorox Co.'s net income of $161M is lower than Kimberly-Clark Corp.'s net income of $391M. Notably, The Clorox Co.'s price-to-earnings ratio is 20.58x while Kimberly-Clark Corp.'s PE ratio is 18.04x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for The Clorox Co. is 2.30x versus 2.12x for Kimberly-Clark Corp.. Usually stocks with elevated PS ratios are considered overvalued.

Kenvue, Inc. has a net margin of 9.62% compared to The Clorox Co.'s net margin of 10.58%. The Clorox Co.'s return on equity of 398.55% beat Kenvue, Inc.'s return on equity of 13.85%.

The Clorox Co. has a consensus price target of $122.06, signalling downside risk potential of -3.08%. On the other hand Kenvue, Inc. has an analysts' consensus of $18.92 which suggests that it could grow by 1.16%. Given that Kenvue, Inc. has higher upside potential than The Clorox Co., analysts believe Kenvue, Inc. is more attractive than The Clorox Co..

The Clorox Co. has a beta of 0.595, which suggesting that the stock is 40.538% less volatile than S&P 500. In comparison Kenvue, Inc. has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

The Clorox Co. has a quarterly dividend of $1.24 per share corresponding to a yield of 3.92%. Kenvue, Inc. offers a yield of 4.43% to investors and pays a quarterly dividend of $0.21 per share. The Clorox Co. pays 75.19% of its earnings as a dividend. Kenvue, Inc. pays out 150.5% of its earnings as a dividend. The Clorox Co.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future, but Kenvue, Inc.'s is not.

The Clorox Co. quarterly revenues are $1.7B, which are smaller than Kenvue, Inc. quarterly revenues of $3.8B. The Clorox Co.'s net income of $161M is lower than Kenvue, Inc.'s net income of $398M. Notably, The Clorox Co.'s price-to-earnings ratio is 20.58x while Kenvue, Inc.'s PE ratio is 25.13x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for The Clorox Co. is 2.30x versus 2.40x for Kenvue, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

Procter & Gamble Co. has a net margin of 9.62% compared to The Clorox Co.'s net margin of 19.5%. The Clorox Co.'s return on equity of 398.55% beat Procter & Gamble Co.'s return on equity of 31.41%.

The Clorox Co. has a consensus price target of $122.06, signalling downside risk potential of -3.08%. On the other hand Procter & Gamble Co. has an analysts' consensus of $167.45 which suggests that it could grow by 4.61%. Given that Procter & Gamble Co. has higher upside potential than The Clorox Co., analysts believe Procter & Gamble Co. is more attractive than The Clorox Co..

The Clorox Co. has a beta of 0.595, which suggesting that the stock is 40.538% less volatile than S&P 500. In comparison Procter & Gamble Co. has a beta of 0.381, suggesting its less volatile than the S&P 500 by 61.916%.

The Clorox Co. has a quarterly dividend of $1.24 per share corresponding to a yield of 3.92%. Procter & Gamble Co. offers a yield of 2.64% to investors and pays a quarterly dividend of $1.06 per share. The Clorox Co. pays 75.19% of its earnings as a dividend. Procter & Gamble Co. pays out 62.63% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

The Clorox Co. quarterly revenues are $1.7B, which are smaller than Procter & Gamble Co. quarterly revenues of $22.2B. The Clorox Co.'s net income of $161M is lower than Procter & Gamble Co.'s net income of $4.3B. Notably, The Clorox Co.'s price-to-earnings ratio is 20.58x while Procter & Gamble Co.'s PE ratio is 23.72x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for The Clorox Co. is 2.30x versus 4.58x for Procter & Gamble Co.. Usually stocks with elevated PS ratios are considered overvalued.